Showing results (1-10 of 261) with videos related to
Sort By:
Pageof 27
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2008
Nicotine and Parkinson's disease: implications for therapyMaryka Quik, Kathryn O'Leary, Caroline M TannerBiochemical Pharmacology|July 17, 2007
Nicotinic receptors as CNS targets for Parkinson's diseaseMaryka Quik, Tanuja Bordia, Kathryn O'LearyThe Journal of Pharmacology and Experimental Therapeutics|February 29, 2008
Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatumKathryn O'Leary, Neeraja Parameswaran, J Michael McIntosh, et al.Annals of Neurology|October 26, 2007
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeysMaryka Quik, Heather Cox, Neeraja Parameswaran, et al.Pharmacological Reviews|October 5, 2011
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's diseaseMaryka Quik, Susan WonnacottMolecular and Cellular Pharmacology|April 19, 2011
Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease TherapeuticsXiomara A Pérez, Maryka QuikNeurotoxicology|November 14, 2002
Nicotine and nicotinic receptors; relevance to Parkinson's diseaseMaryka Quik, Jennifer M KulakThe Journal of Pharmacology and Experimental Therapeutics|October 8, 2005
Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapyMaryka Quik, J Michael McIntoshMovement Disorders : Official Journal of the Movement Disorder Society|June 14, 2012
Nicotine as a potential neuroprotective agent for Parkinson's diseaseMaryka Quik, Xiomara A Perez, Tanuja BordiaPageof 27